日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

儿童脑肿瘤会影响颅内造血和免疫耐受。

Cooper Elizabeth, Posner David A, Lee Colin Y C, Hu Linda, Bonner Sigourney, Taylor Jessica T, Baldwin Oscar, Jimenez-Guerrero Rocio, Masih Katherine E, Rahrmann Katherine Wickham, Eigenbrood Jason, Ngo Gina, Franklin Valar Nila Roamio, D'Santos Clive S, Mair Richard, Santarius Thomas, Craven Claudia, Jalloh Ibrahim, Moreno Vicente Julia, Halim Timotheus Y F, Wang Li, Kreigstien Arnold R, Wainwright Brandon, Swartling Fredrik J, Khan Javed, Clatworthy Menna R, Gilbertson Richard J

Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma.

利用非病毒 TcBuster 转座子工程改造 CD70-CAR 自然杀伤细胞,用于治疗骨肉瘤。

Robbins Gabrielle M, Chang Jae-Woong, Krueger Joshua B, Vue Young Y, Gilkey Alexandria K, Folsom Timothy D, Jubenville Tyler, Skeate Joseph G, Langworthy Benjamin W, Fitzgerald Katelyn M, Peterson Joseph J, Stelljes Erin M, Largaespada David A, Rahrmann Eric P, Webber Beau R, Moriarity Branden S

miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification Approach

基于miRNA的乳腺癌亚型分型:采用AHALA多阶段分类方法

Qaraad, Mohammed; Rahrmann, Eric P; Guinovart, David

NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14

NF1 依赖的血神经屏障破坏可通过阻断 P2RY14 得到改善

Jennifer Patritti-Cram, Eric P Rahrmann, Tilat A Rizvi, Katherine C Scheffer, Timothy N Phoenix, David A Largaespada, Nancy Ratner

Osteosarcoma: A comprehensive review of model systems and experimental therapies

骨肉瘤:模型系统和实验疗法的全面综述

Robbins, Gabrielle M; Vue, Young Y; Rahrmann, Eric P; Moriarity, Branden S

KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomas

KCNQ 钾通道调节胃食管腺癌中的 Wnt 活性

David Shorthouse, Lizhe Zhuang, Eric P Rahrmann, Cassandra Kosmidou, Katherine Wickham Rahrmann, Michael Hall, Benedict Greenwood, Ginny Devonshire, Richard J Gilbertson, Rebecca C Fitzgerald, Benjamin A Hall

The NALCN channel regulates metastasis and nonmalignant cell dissemination

NALCN通道调控转移和非恶性细胞扩散

Eric P Rahrmann ,David Shorthouse ,Amir Jassim ,Linda P Hu ,Mariaestela Ortiz ,Betania Mahler-Araujo ,Peter Vogel ,Marta Paez-Ribes ,Atefeh Fatemi ,Gregory J Hannon ,Radhika Iyer ,Jay A Blundon ,Filipe C Lourenço ,Jonathan Kay ,Rosalynn M Nazarian ,Benjamin A Hall ,Stanislav S Zakharenko ,Douglas J Winton ,Liqin Zhu ,Richard J Gilbertson

SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

SEMA4C 是限制骨肉瘤生长、进展和转移的新靶点

Branden A Smeester, Nicholas J Slipek, Emily J Pomeroy, Heather E Bomberger, Ghaidan A Shamsan, Joseph J Peterson, Margaret R Crosby, Garrett M Draper, Kelsie L Becklin, Eric P Rahrmann, James B McCarthy, David J Odde, David K Wood, David A Largaespada, Branden S Moriarity

Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma

ZNF217 在加速肿瘤发展中的作用以及针对 ZNF217 诱导的 PI3K-AKT 信号治疗转移性骨肉瘤的意义

Branden A Smeester #, Garrett M Draper #, Nicholas J Slipek, Alex T Larsson, Natalie Stratton, Emily J Pomeroy, Kelsie L Becklin, Kenta Yamamoto, Kyle B Williams, Kanut Laoharawee, Joseph J Peterson, Juan E Abrahante, Susan K Rathe, Lauren J Mills, Margaret R Crosby, Wendy A Hudson, Eric P Rahrmann,

Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity

更正:在两种基因工程小鼠雪旺细胞肿瘤模型中同时靶向 MAPK 和 PI3K/AKT/mTOR 通路可降低肿瘤等级和多发性

Adrienne L Watson #, Bryant J Keller #, Kyle A Williams, Namrata N Damle, Samuel J Finnerty, Leah K Anderson, Andrew D Greeley, Vincent W Keng, Eric P Rahrmann, Amanda L Halfond, Natasha M Powell, Margaret H Collins, Tilat Rizvi, Christopher L Moertel, Nancy Ratner, David A Largaespada